Clinical inertia: How is it possible?;Inertie clinique : Comment est-elle possible?

Medecine des Maladies Metaboliques

Volumn 5, Issue 5, 2011, Pages 567-573

  Reach, Gérard ^a,b  

^a AVICENNE HOSPITAL   (France)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

adherence; Clinical inertia; physician patient relationship; trust

Indexed keywords

ARTICLE; CLINICAL INERTIA; DOCTOR PATIENT RELATION; EVIDENCE BASED MEDICINE; HUMAN; PATIENT CARE; TREATMENT REFUSAL;

EID: 84857743680     PISSN: 19572557     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1957-2557(11)70317-0     Document Type: Article

References (41)

1. World health organization (WHO). Adherence to long-term therapies: Evidence for Action. WHO Library Cataloguing-in-Publication Data. Genève: WHO, 2003:11.
2. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001;135:825-34. (Pubitemid 33051266)
3. Scheen AJ, Giet D. Cibler l'inertie et le défaut d'observance thérapeutiques : Nouveau défi pour améliorer les performances de la pratique médicale. éditorial. Rev Méd Liège 2010;65:229-31.
4. Shah BR, Hux JE, Laupacis A, et al. Clinical inertia in response to inadequate glycemic control. Do specialists differ from primary care physicians? Diabetes Care 2005;28:600-6. (Pubitemid 40326231)
5. Brown JB, Nichols GA. Slow response to loss of glycemic control in type 2 diabetes mellitus. Am J Manag Care 2003;9:213-7. (Pubitemid 36372212)
6. Bouée S, Detournay B, Balkau B, et al. Diabète de type 2 : Pratiques d'intensification thérapeutique chez les médecins généralistes en France en 2008-2009. Bull épidémiol Hebd (BEH) 2010;42- 43:436-40.
7. Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care 2004;27:1535-40. (Pubitemid 38857422)
8. Okonofua EC, Simpson KN, Jesri A, et al. Therapeutic inertia is an impediment to achieving the healthy people 2010 blood pressure control goals. Hypertension 2006;47:345-51. (Pubitemid 43740273)
9. American diabetes association. Clinical practice recommendations 1999. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1999;22(Suppl.1):S32-S41.
10. el-Kebbi IM, Ziemer DC, Gallina DL, et al. Diabetes in urban African-Americans. XV. Identification of barriers to provider adherence to management protocols. Diabetes Care 1999;22:1617-20. (Pubitemid 29458382)
11. Kerr EA, Zikmund-Fisher BJ, Klamerus ML, et al. The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Ann Intern Med 2008;148:717-27. (Pubitemid 351717417)
12. Bachimont J, Cogneau J, Letourmy A. Pourquoi les médecins généralistes n'observent-ils pas les recommandations de bonnes pratiques cliniques ? L'exemple du diabète de type 2. Sciences Sociales et Santé 2006;24:75-104.
13. Cogneau J, Lehr-Drylewicz AM, Bachimont J, Letoumy A. écarts entre le référentiel et la pratique dans le diabète de type 2 : Les préjugés des médecins et des patients sont un obstacle à une éducation efficace des patients. Presse Méd 2007;36:764-70.
14. Parchman ML, Pugh JA, Romero RL, Bowers KW. Competing demands or clinical inertia: The case of elevated glycosylated hemoglobin. Ann Fam Med 2007;5:196-201. (Pubitemid 46889995)
15. Turner BJ, Hollenbeak CS, Weiner M, et al. Effect of unrelated comorbid conditions on hypertension management. Ann Intern Med 2008;148:578-86. (Pubitemid 351669131)
16. Jandrain B, Ernest P, Radermecker RP, Scheen AJ. Stratégies pour éviter l'inertie et la non-observance dans les essais cliniques. Rev Méd Liège 2010;65:246-9.
17. Ferrari P; National Coordinators for the Reasons for not Intensifying Antihypertensive Treatment (RIAT) trial 12. Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries. J Human Hypertens 2009;23:151-9.
18. Davidson D. Actions et événements. Essai 2 : Comment la faiblesse de la volonté est-elle possible ? Traduction par Pascal Engel. Collection Epimethée. Paris: Presses Universitaires de France (PUF), 1993.
19. Grant R, Adams AS, Trinacty CM, et al. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care 2007;30:807-12. (Pubitemid 46556571)
20. Leslie CA, Satin Rapaport W, Matheson D, et al. Psychological insulin resistance: A missed diagnosis. Diabetes Spectrum 1994;7:52-7.
21. Phillips P. Type 2 diabetes-failure, blame and guilt in the adoption of insulin therapy. Rev Diabet Stud 2005;2:35-9.
22. Wallace TM, Matthews DR. Poor glycaemic control in type 2 diabetes: A conspiracy of disease, suboptimal therapy and attitude. QJM 2000;93:369-74. (Pubitemid 30386809)
23. Reach G. Patient non-Adherence and healthcare- provider inertia are clinical myopia. Diabetes Metab 2008;34:382-5.
24. Lindenauer PK, Remus D, Roman S, et al. Public reporting and pay for performance in hospital quality improvement. N Engl J Med 2007;356:486-96. (Pubitemid 46193076)
25. www.sfmg.org/groupe-de-pairs/(accédé le 9 avril 2011).
26. Rogers CR. A theory of therapy, personality and interpersonal relationships as developed in the client-centered framework. In: Koch S, ed. Psychology: A study of a science. Vol. 3: Formulations of the person and the social context. New York: McGraw Hill, 1959.
27. Wispé L. The distinction between sympathy and empathy: To call for a concept, a word is needed. J Pers Soc Psychol 1996;50:314-21.
28. Elster J. Ulysses unbound: Studies in rationality, precommitment, and constraints. Cambridge: Cambridge University Press, 2000.
29. Thiboutot J, Stuckey H, Binette A, et al. A web-based patient activation intervention to improve hypertension care: Study design and baseline characteristics in the web hypertension study. Contemp Clin Trials 2010;31:634-46.
30. Philips JC, Scheen AJ. Inertie clinique dans la prise en charge du patient diabétique de type 2 : Quelles solutions proposer ? Rev Méd Liège 2010;65:318-25.
31. Cochrane AL. Effectiveness and efficiency: Random reflections on health services. London: National Health Services, 1972.
32. Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA 1992;268:2420-5.
33. Miller LV, Goldstein J. More efficient care of diabetic patients in a county-hospital setting. N Engl J Med 1972;286:1388-91.
34. Beauchamp TL, Childress JF. Principles of biomedical ethics. Oxford, New York, Toronto: Oxford University Press, 2001.
35. Sackett DL. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in health care. Baltimore: John Hopkins University Press, 1979.
36. Zikmund-Fisher BJ, Hofer TP, Klamerus ML, Kerr EA. First things first: Difficulty with current medications is associated with patient willingness to add new ones. Patient 2009;2:221-31.
37. Nguyen GC, LaVeist TA, Harris ML, et al. Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis 2009;15:1233-9.
38. Origgi G. Qu'est-ce que la confiance ? Collection Chemins philosophiques. Paris: Vrin, 2008:7-8.
39. Thom DH, Kravitz RL, Bell RA, et al. Patient trust in the physician: Relationship to patient requests. Fam Pract 2002;19:476-83. (Pubitemid 35244232)
40. O'Neill O. Autonomy and trust in bioethics. Cambridge: Cambridge University Press, 2002.
41. Reach G. Une théorie du soin - Souci et amour face à la maladie. Préface de Bernard Baertschi. Collection Médecine & Sciences humaines. Paris: Belles Lettres, 2010.